Nordhealth AS (OSL:NORDH) Total Operating Expense: kr648.8 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSL:NORDH Nordhealth AS OSL:NORDH
72 GF Score
Price kr23.80
GF Value kr39.29
Valuation Significantly Undervalued
! 1 Warning Sign
View Full Analysis

What is Nordhealth AS Total Operating Expense?

Nordhealth AS OSL:NORDH +0.85% 72 Total Operating Expense is kr648.8 Mil as of Mar. 2026. GuruFocus rates OSL:NORDH with a GF Score™ of 72/100 and a GF Value™ of kr39.29 (Significantly Undervalued). The stock has 1 warning sign investors should review.

Nordhealth AS's Total Operating Expense for the three months ended in Mar. 2026 was kr170.7 Mil. Nordhealth AS's Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was kr648.8 Mil.

Nordhealth AS Total Operating Expense Related Terms

Nordhealth AS Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Nordhealth AS's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nordhealth AS Total Operating Expense Chart

Nordhealth AS Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Operating Expense
Get a 7-Day Free Trial 215.10 428.57 495.16 549.28 636.29

Nordhealth AS Quarterly Data
Apr21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 149.03 161.41 147.87 168.79 170.71
OSL:NORDH
72GF Score
Nordhealth AS OSL:NORDH
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nordhealth AS Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr648.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of kr648.8 Mil mean?
Nordhealth AS (OSL:NORDH) has a Total Operating Expense of kr648.8 Mil as of Mar. 2026. Total operating expense is the primary recurring expense associated with central operations. View historical data on Nordhealth AS and its competitors.
Is Nordhealth AS's Total Operating Expense too high?
Nordhealth AS's current Total Operating Expense is kr648.8 Mil. Overall, Nordhealth AS has a GF Score™ of 72/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Nordhealth AS's Total Operating Expense compare to VEEV and BTSG?
Nordhealth AS's Total Operating Expense of kr648.8 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Healthcare Providers & Services company?
A good Total Operating Expense depends on the Healthcare Providers & Services industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Nordhealth AS and its competitors. Nordhealth AS's current Total Operating Expense is kr648.8 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nordhealth AS stock overvalued right now?
Based on GuruFocus' analysis, Nordhealth AS (OSL:NORDH) is currently considered Significantly Undervalued. The stock's GF Value™ is kr39.29, compared to a current price of kr23.80 — trading 39.4% below its estimated fair value. The current Total Operating Expense is kr648.8 Mil. Nordhealth AS's overall GF Score™ is 72/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Nordhealth AS (OSL:NORDH), the current Total Operating Expense is kr648.8 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nordhealth AS (OSL:NORDH) Overvalued in 2026?

Based on GuruFocus' analysis, Nordhealth AS stock appears to be undervalued. The current stock price of kr23.80 is trading 39.4% below its estimated GF Value™ of kr39.29. GuruFocus considers Nordhealth AS to be Significantly Undervalued.

Key valuation signals for OSL:NORDH:

  • Total Operating Expense: kr648.8 Mil
  • GF Value™: kr39.29 vs. price of kr23.80 (39.4% below fair value)
  • GF Score™: 72/100 with 1 warning sign

No single metric tells the full story. See the OSL:NORDH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Nordhealth AS Business Description

Address Hasleveien 28A, Oslo, NOR, 0571
Nordhealth AS is a cloud-based healthcare Software-as-a-Service business. Its flagship Practice Management Software (PMS), Provet for veterinary practices and Therapy Unified Platform for therapy practices, assist healthcare professionals to streamline operations and improve patient care. The majority of its revenue is generated through software subscriptions. The Group also offers additional services related to the implementation of the SaaS systems, including consultancy services, education, and data conversion. Its operating segments are: Veterinary, which generates the majority of revenue, Therapy, and Other. Geographically, Nordhealth derives maximum revenue from Norway, and the rest from Finland, the United Kingdom, Sweden, Denmark, the DACH region, and other countries.
72GF Score

Get the complete analysis for OSL:NORDH

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr23.80
Price
kr39.29
GF Value